Farrow Jeffrey S
SEC insider (Form 3/4/5 filer). CIK 0001405253. Director at LISATA THERAPEUTICS, INC. (LSTA) and 2 other issuers. 20 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in LIBERTY CORNER, NJ.
Companies Farrow Jeffrey S has filed insider reports for
- LISATA THERAPEUTICS, INC. (LSTA): Director
- ACHIEVE LIFE SCIENCES, INC. (ACHV): Director
- Tarsus Pharmaceuticals, Inc. (TARS): Officer, See Remarks
Farrow Jeffrey S
CIK: 0001405253
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jul 27, 2026ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectStock Option (right to buy)
25K shares- - Jul 27, 2026ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectRestricted Stock Unit (RSU)
16.7K shares- - Jun 16, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect14.4K shares at avg. $60.95$877K - Jun 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect27.9K shares- - May 29, 2026ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectStock Option (right to buy)
47.3K shares- - Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect2.2K shares at avg. $67.00$146K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect2.1K shares at avg. $68.71$147K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect2.1K shares at avg. $69.42$147K - Mar 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect13K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
30.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 27, 2026 |  ACHV ACHIEVE LIFE SCIENCES, INC. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Jul 27, 2026 | ACHV ACHIEVE LIFE SCIENCES, INC. | Award Restricted Stock Unit (RSU) | 16,700 | - | - | Direct |
| Jun 16, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Sale | 14,396 | $60.95 | $877,436 | Direct |
| Jun 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 27,881 | - | $0 | Direct |
| May 29, 2026 | ACHV ACHIEVE LIFE SCIENCES, INC. | Award Stock Option (right to buy) | 47,250 | - | - | Direct |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,186 | $67.00 | $146,462 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,133 | $68.71 | $146,558 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,111 | $69.42 | $146,546 | Direct |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 13,042 | - | $0 | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 30,724 | - | - | Direct |
1-10 of 20 transactions